The study documents experiences and unmet support needs; it does not estimate how common these problems were across all people with breast cancer or test whether particular interventions improve outcomes. Researchers recruited participants through posters, community newsletters and social media between April 2023 and April 2024. Eligible adults were at least 18 years old, had a histologically confirmed diagnosis of primary stage I, II or III breast cancer, were actively receiving or had completed surgery, radiation, chemotherapy or hormone therapy within the previous year, and lived in interior British Columbia.

People with self-reported distant metastatic disease, those receiving end-of-life or palliative care, and those whose cognitive or neurological impairments prevented informed consent or participation were excluded. Recruitment used purposive sampling, with 12 interviews conducted face to face and 16 online. Each semi-structured interview lasted about 60 to 75 minutes and covered the diagnosis experience, navigation of cancer services, psychosocial and daily-life effects, relationships, financial and occupational challenges, coping and recommended resources.

The interview guide was developed through a three-stage process informed by a supportive-care framework and recent qualitative research. Two oncology nurse specialists, a behavioral psychologist and two people with lived experience of a new breast cancer diagnosis reviewed its questions. A pilot with five eligible participants tested clarity and emotional safety, after which pacing was adjusted slightly.

Transcripts were analyzed in NVivo 14 using directed qualitative content analysis and a deductive-inductive framework. Meaning units could range from words or sentences to paragraphs, and the researchers combined a formative matrix with emergent subcategories. Coding was supported through verbatim transcription, reflexive journals, an audit trail and reconciliation of discrepancies by two independent coders.

Transitional care emerged as the first major category. Participants described uncertainty about whom to contact after diagnosis or treatment, limited continuity between clinicians, inadequate information about available programs, and insufficient advocacy. One participant said a breast cancer survivor group became a “salvation” after a brief exchange with a physician left them feeling unsupported.

Another described losing access to a family doctor when the physician moved, with records not being transferred for two years. Support groups helped participants feel connected, while peer relationships offered reassurance from people who could relate to their experiences. However, these accounts do not establish that mentorship was more valuable when it arrived late, nor do they demonstrate the effectiveness of any particular support group.

Instead, they identify unmet needs for navigation, advocacy, follow-up and accessible information. Participants also described a lack of professional guidance concerning sexuality, body image and intimacy. Some requested support specifically for the effects of aromatase inhibitors, as well as counseling for body dysmorphia and depression after diagnosis.

One participant described an evening hospital group as the only available option but said its timing was too late for people who became exhausted during treatment. Another said they received neither therapy nor counseling and wanted access to nurse navigators, emotional-support counselors, financial counseling and assistance for family members. These preferences were expressed within the first year after diagnosis, when some participants were still undergoing treatment and others had already completed primary therapy.

The findings reveal gaps in information and support, not measured rates of sexual dysfunction, depression or treatment-related body dissatisfaction. Physical symptoms and the cost of care combined to reduce quality of life. Participants described fatigue, pain, nausea, brain fog and other treatment effects, as well as expenses for transportation, parking, meals, accommodation and supportive services.

One participant reported attending hospital appointments as often as three times a week and struggling with parking costs; the account concerned repeated outpatient visits rather than hospitalization. Several traveled long distances for diagnostic testing, surgery, radiation or follow-up appointments, and one described staying in a cancer lodge during radiation. Because the research was qualitative, it cannot quantify the average cost of travel or financial toxicity.

It nevertheless shows that repeated journeys could consume time, wages and savings, while specialized care in larger centers could require temporary lodging and extended absences from work and family life. Employment disruption was closely connected to these financial and psychological burdens. Participants described sick leave, reduced working hours, disability benefits, difficulty returning to full-time work, early retirement and loss of pension contributions.

Fatigue, anxiety, cognitive problems, medical appointments and side effects limited their capacity to work, while fear of recurrence made returning to a previous workload more difficult. Family members also faced consequences through unpaid leave, early retirement, childcare and household care. One participant linked repeated specialist trips and radiation treatment to time away from work and the need to borrow money.

Another described depleted retirement savings and out-of-pocket costs for care, transport and accommodation. These accounts show that the effects of diagnosis could extend to household finances and employment plans, although the study did not calculate income loss or compare outcomes with a control group. Emotional distress was expressed through fear of recurrence, fear of dying, anxiety, sadness, anger and hypervigilance about physical symptoms.

Participants described checking their bodies, interpreting unexplained sensations as possible recurrence, rumination about mortality and difficulty planning. Treatment-related distress also affected mobility, travel and participation in family activities. One participant said fear of recurrence diminished their sense of control and ability to make retirement plans.

Another described enduring distress after chemotherapy, radiation, multiple surgeries, infection and treatment effects involving the heart and lungs. Some maintained an outward appearance of resilience to avoid worrying relatives, while others withdrew or suppressed emotions to preserve household harmony. The researchers interpreted this concealment as an avoidant coping response that could leave participants isolated, but the interviews do not determine whether such behavior was typical or clinically harmful at a population level.

The third category concerned body identity, interpersonal relationships, sexuality and dysmorphia. Participants described hair loss, mastectomy, lymphedema, menopause, surgical scars, asymmetric reconstruction and endocrine-therapy effects on desire and intimacy. Hair loss and scars were described as visible reminders of cancer and treatment, contributing to shame, embarrassment and reduced confidence.

Some participants avoided being seen by partners or withdrew from sexual relationships, while others said they were reluctant to communicate their physical or emotional needs. Family members provided important practical and emotional support, yet communication barriers could leave relatives unaware of the full extent of a participant’s distress. Conversations with doctors and nurses sometimes helped participants understand treatment and side effects, participate in decisions and articulate their needs.

The findings therefore show that relationships could be both sources of support and sites where unresolved distress remained hidden. The authors recommend integrating professional nurse mentorship and navigation from biopsy onward, routinely screening for emotional distress and financial toxicity, and providing specialized counseling concerning body image, menopause, reproductive health, sexual function and treatment effects. They also propose inclusive support groups with flexible schedules, travel and lodging assistance, and hybrid oncology networks combining virtual specialist consultations with local community services.

These recommendations derive from participants’ reported experiences rather than from trials of effectiveness. Important limitations include the regional setting, purposive recruitment, possible self-selection through community and survivor networks, a cross-sectional design and a sample of 28. Most participants were women, while men and non-binary people were insufficiently represented.

The findings nevertheless provide a detailed account of how care for newly diagnosed breast cancer in rural and remote communities can extend beyond treatment itself to navigation, employment, finances, relationships, identity and intimacy.

Subject of Research: Psychosocial and quality-of-life experiences of adults newly diagnosed with breast cancer in interior British Columbia

Article Title: Lived experiences of psychosocial and quality of life outcomes for adults newly diagnosed with breast cancer in interior British Columbia: qualitative research

Article References: D’Souza, M. S., Manish, A., Nette, H., & Bacsu, J.-D. R. (2026). Lived experiences of psychosocial and quality of life outcomes for adults newly diagnosed with breast cancer in interior British Columbia: qualitative research. Frontiers in Global Women's Health, 7, 1828624. https://doi.org/10.3389/fgwh.2026.1828624

Image Credits: AI Generated

DOI: 10.3389/fgwh.2026.1828624

Keywords: breast cancer, qualitative research, rural health, quality of life, patient navigation, financial toxicity, sexual health, body image, fear of recurrence, early survivorship, Lived, experiences

The symposium program will include presentations on using AI in cancer prevention and care delivery, addressing distance as a barrier for rural communities, overcoming challenges to innovation through public-private partnerships, optimizing digital health strategies and transforming patient navigation. These are announced discussion topics rather than research findings. The release does not report new study results, clinical outcomes, effect estimates or evidence that any particular AI or digital-health intervention has improved cancer prevention or care. Its scope is a multidisciplinary conference for leaders and specialists to exchange perspectives and engage with emerging approaches to cancer care delivery.

David C. Rhew, MD, Global Chief Medical Officer and Vice President of Health and Life Sciences at Microsoft, and Robin Vanderpool, DrPH, chief of the Health Communication and Informatics Research Branch in the Division of Cancer Control and Population Sciences at the National Cancer Institute, are the announced keynote speakers. Tracy Onega, PhD, MA, MPAS, MS, senior director of population sciences at Huntsman Cancer Institute and professor of population sciences at the University of Utah, and Thomas Varghese, MD, MS, MBA, FACS, MAMSE, associate chief medical quality officer and chief value officer at Huntsman Cancer Institute and professor and chief of general thoracic surgery at the University, will serve as co-chairs. Featured speakers listed in the announcement include Thomas Osborne, MD, Chief Medical Officer at Microsoft; Electra Paskett, PhD, director of the Division of Cancer Prevention and Control in The Ohio State University College of Medicine; Roy Jensen, MD, vice chancellor and director of the University of Kansas Cancer Center; David Wetter, PhD, MS, senior director for Cancer Health Implementation at Huntsman Cancer Institute and professor of population health sciences at the University of Utah; and Peggy Han, PharmD, vice president of Customer Engagement at Genentech. Shane Jacobsen, CEO of the American Cancer Society, is listed as a tentative featured speaker, and panel discussions are part of the program.

Huntsman Cancer Institute characterized the event as an opportunity for scientists, clinicians and computational experts to discuss how artificial intelligence and other emerging technologies could transform cancer prevention, diagnosis and care. Neli Ulrich, PhD, MS, chief scientific officer and executive director of the institute’s Comprehensive Cancer Center, professor of population health sciences at the University of Utah and a member of the symposium program committee, said: “By bridging disciplines and sectors, we can push boundaries, accelerate the translation of innovative approaches into meaningful clinical advances, and unlock new possibilities for understanding, preventing, and treating cancer.” The institute is an National Cancer Institute-designated Comprehensive Cancer Center for Utah, Idaho, Montana, Nevada and Wyoming. It reports more than 400 open clinical trials and 300 research teams studying cancer at any given time. Registration and the call for abstracts are available through the symposium website.

Subject of Research: A 2027 multidisciplinary symposium on artificial intelligence, access and cancer care delivery

Article Title: Huntsman Cancer Institute to host Frontiers Symposium on AI, Access, and Action: Transforming Cancer Care Delivery

Article References: Huntsman Cancer Institute to host Frontiers Symposium on AI, Access, and Action: Transforming Cancer Care Delivery. Original publication (Bibliographic details unavailable.)

Image Credits: AI Generated

DOI: Not provided

Keywords: Huntsman Cancer Institute, artificial intelligence, cancer care delivery, digital health, rural health, patient navigation, public-private partnerships, cancer prevention, clinical research, University of Utah, Huntsman, Cancer

Researchers analyzed secondary data from the 358 participating community health workers, or CHWs. Each worker reported whether they had observed at least one child with a physical or mental disability in their community. The sample’s median age was 45 years, and 57.7% of participants were female. Descriptive statistics summarized workers’ characteristics and their reported observations, while bivariate and multivariable logistic regression analyses examined factors associated with reporting childhood disabilities.

The most frequently reported physical conditions were genu valgum, mentioned by 38.3% of participating workers; clubfoot, reported by 36.1%; and hearing impairment, reported by 34.0%. For mental or developmental conditions, 40.1% of workers reported observing developmental delay and 21.7% reported epilepsy. These figures represent the percentages of health workers who mentioned each condition, not the percentages of children who had it. The design therefore describes the range and frequency of workers’ observations but cannot establish how many children in Rwanda live with each disability.

Referral was a prominent part of workers’ reported activity: 94.6% said they had referred cases to health facilities. The regression analysis identified two factors associated with whether workers reported observing children with disabilities. Female workers had higher odds of reporting a case than male workers, with an adjusted odds ratio of 2.03, a 95% confidence interval of 1.27–3.23 and a p-value of 0.003. Workers with 11–15 years of experience also had higher odds of reporting childhood disabilities than those with fewer than five years of experience, with an adjusted odds ratio of 2.22, a 95% confidence interval of 1.08–4.56 and a p-value of 0.030. These statistical associations do not establish that gender or experience caused differences in reporting.

The findings position community health workers as potential identifiers and referral points for childhood disabilities in rural, low-resource settings, where access to early diagnosis, care and support systems may be limited. The researchers concluded that strengthening workers’ capacity through targeted training, screening tools and improved referral systems may enhance early identification and equitable access to care. The study itself did not test those interventions or measure whether stronger screening and referral systems improve child outcomes. It instead provides descriptive evidence about the conditions workers reported observing, their referral activity and the worker characteristics associated with reporting a case. Direct child-level assessment would be required to estimate population prevalence, while evaluation of training, screening and referral approaches would be needed to determine whether they improve diagnosis and care.

Subject of Research: Community health worker reports of childhood physical and mental disabilities in rural Rwanda

Article Title: Community health worker–reported observations of physical and mental disabilities among children in rural setting in Rwanda

Article References: Umurerwa, M., uwimpuhwe, D., Dukuzimana, M. J., Franke, M. A., Mukundwa, P. N., & Ngwakongnwi, E. (2026). Community health worker–reported observations of physical and mental disabilities among children in rural setting in Rwanda. BMC Health Services Research. https://doi.org/10.1186/s12913-026-15875-3

Image Credits: AI Generated

DOI: 10.1186/s12913-026-15875-3

Keywords: Rwanda, childhood disability, community health workers, rural health, physical disability, mental disability, developmental delay, clubfoot, hearing impairment, health referrals, Community, health

The research team, led by Ludovic Deo Gracias Tapsoba of Joseph Ki-Zerbo University in Ouagadougou and including collaborators from Ghana, the United Kingdom and Canada, set out to fill a stubborn evidence gap. Burkina Faso has national policies on adolescent health, but little facility-level data existed on whether the primary healthcare facilities that serve as the main entry point for these services actually have the staff, equipment and medicines to deliver them. The study focused on two purposively selected regions, Centre-Ouest and Hauts-Bassins, chosen to capture different geographic and epidemiological contexts in the western and southwestern parts of the country.

Within those regions, the researchers randomly selected health districts and then sampled facilities by systematic random sampling proportional to size, a design intended to give larger facility networks a fair chance of inclusion while preserving statistical representativeness. The final sample of 152 facilities was dominated by Health and Social Promotion Centers, the community-level facilities that constitute the backbone of Burkina Faso’s primary care system, which accounted for 77.6 percent of the surveyed sites. Medical centers and medical centers with surgical units made up the remainder, alongside a small number of private and faith-based facilities.

To measure capacity, the team adapted the World Health Organization’s Service Availability and Readiness Assessment tool, a standardized instrument used across low- and middle-income countries to benchmark health facility performance. Availability was assessed across three service domains: family planning, sexual health education and rights, and antenatal care. Readiness was measured across three parallel dimensions: trained personnel, diagnostic capabilities and essential medicines. The study’s headline metric, full availability, was an all-or-nothing composite requiring every component across all three domains to be present in a single facility. That conservative construction means the 30.3 percent figure should be read as a floor for comprehensive service delivery rather than a conventional coverage indicator.

The urban-rural divide was the study’s most statistically robust finding. Full availability was significantly higher in urban facilities than in rural ones, at 46.5 percent versus 23.9 percent, a between-group difference with a 95 percent confidence interval of 5.7 to 39.6 and a p-value of 0.006. In a country where the majority of adolescents live outside cities, that gap matters. A teenager in a rural village is roughly half as likely to find a clinic equipped to provide the complete package of adolescent sexual and reproductive health services as a teenager in an urban center, even when both clinics report offering some services.

Readiness gaps were even more pronounced than availability gaps, particularly for diagnostic capacity and staff training. Syphilis-testing capacity was very low overall and significantly higher in urban than rural facilities, at 23.2 percent versus 4.6 percent, with a 95 percent confidence interval of 7.1 to 33.4 and a p-value of 0.001. Congenital syphilis remains a preventable cause of stillbirth and neonatal death across sub-Saharan Africa, so the near-absence of testing capacity in rural clinics represents a concrete clinical risk. Staff recently trained in refocused antenatal care, a WHO-endorsed model that concentrates visits around evidence-based interventions, were also more common in urban areas, at 53.4 percent versus 33.0 percent, with a 95 percent confidence interval of 3.1 to 37.8 and a p-value of 0.020.

Not every comparison reached statistical significance. Full availability did not differ significantly between the two regions, at 28.6 percent in Centre-Ouest versus 32.0 percent in Hauts-Bassins, with a p-value of 0.65, suggesting the problem is systemic rather than confined to one geographic area. Differences across facility types were based on small subgroups and should be interpreted with caution, the authors note. The broader pattern, however, points to particular weakness in Health and Social Promotion Centers and in private and faith-based facilities, which are precisely the sites that rural adolescents are most likely to encounter first.

The study’s implications reach beyond Burkina Faso. Across West Africa, adolescent sexual and reproductive health remains one of the most politically and culturally contested areas of public health, and facility-level evidence of this kind is rare. The research was supported by a grant from the UK Medical Research Council and the Foreign, Commonwealth and Development Office, in collaboration with the UK Department of Health and Social Care, reflecting growing international investment in the ADOWA initiative, which examines adolescent mental, sexual and reproductive health policy and primary care implementation priorities across the region. Ethical approval was granted by Burkina Faso’s National Ethics Committee for Health Research, and all facility data were anonymized before analysis.

What makes the findings actionable is the specificity of the readiness gaps. The authors identify in-service training, particularly in refocused antenatal care, as a priority, alongside strengthening the availability of family planning methods and adolescent education activities in rural areas. For Health and Social Promotion Centers and private facilities, the priorities are more infrastructural: clinical guidelines, diagnostic capacity and reliable supply chains. These are not exotic interventions. They are the unglamorous plumbing of a health system, and the study suggests that in Burkina Faso that plumbing is leaking at exactly the joints where adolescent patients pass through.

The timing is significant. Burkina Faso’s adolescent population is growing, and the country faces overlapping pressures from insecurity and displacement that strain rural health services. As the authors conclude, availability and readiness of primary healthcare facilities to provide full adolescent sexual and reproductive health services remain limited, especially in rural facilities and in the community-level centers that dominate the primary care landscape. For a health system built on the promise that every clinic is a doorway to care, the study is a reminder that a doorway is only useful if the room behind it is equipped. The full open-access article, with complete subgroup comparisons by region, facility type and residence, is available online.

Subject of Research: Health Services Research

Article Title: Availability and readiness of primary healthcare facilities in the provision of adolescent sexual and reproductive health services in two regions of Burkina Faso: a cross-sectional study

Article References: Tapsoba, L. D. G., Amenah, M. A., Traoré, S., Da Silva, R. B., & Meda, Z. C. (2026). Availability and readiness of primary healthcare facilities in the provision of adolescent sexual and reproductive health services in two regions of Burkina Faso: a cross-sectional study. BMC Health Services Research. https://doi.org/10.1186/s12913-026-15649-x

Image Credits: AI Generated

DOI: 10.1186/s12913-026-15649-x

Keywords: Burkina Faso, adolescent health, primary healthcare, reproductive health, family planning, health facilities, rural health, West Africa, Availability, readiness, primary, healthcare

The numbers behind the study are sobering. Among the 4,004 patients diagnosed between 2010 and 2019, 23 percent died within six months of diagnosis. That figure, the authors argue, is not simply a reflection of aggressive biology. It is also a signal of inequities in how health care is delivered and accessed. Patients diagnosed with de novo metastatic disease are especially vulnerable to disparities in health equity and access to care, and most previous work on this question has come from the United States, leaving a gap in Canadian data that the research team set out to fill.

Breast cancer is the most common cancer among women in Canada, with roughly one in eight females receiving a diagnosis during their lifetime. In Ontario alone, about 3,000 patients are diagnosed annually, and de novo metastatic disease accounts for 3 to 6 percent of all breast cancer diagnoses. Although advances in systemic therapy have extended survival for many people with metastatic disease, the benefits have not been distributed evenly. The study asked whether differences in access and social circumstances could help explain why some patients die so soon after learning they have cancer.

Methodologically, the researchers drew on ICES, an Ontario-based research institute holding linked health administrative data covering the province’s population. They applied the Ontario Marginalization Index, a validated tool that quantifies dimensions of marginalization across neighborhoods, including housing stability, income, age, and employment status. By linking these sociodemographic measures to clinical outcomes, the team could test whether marginalization was independently associated with early mortality after adjusting for other factors.

The results pointed clearly in one direction. Among patients who died within six months, older age, the presence of chronic illness, and higher levels of housing and income marginalization were all associated with early death. In practical terms, people living in unstable housing situations or in low-income neighborhoods were more likely to be diagnosed with disease so advanced that survival measured in months rather than years, and once diagnosed, they died faster than their more advantaged counterparts.

Access to primary care emerged as one of the most consequential and modifiable factors. Patients who were linked to a family physician had 26 percent lower odds of early death, and they were also more likely to have received a mammogram within the two years preceding their diagnosis. The authors note that access to a primary care provider is a growing challenge in Canada, with one in four Canadians lacking regular access to primary care. Without a consistent provider, symptoms may go unexamined, screening may lapse, and the path from first concern to diagnosis and treatment can stretch out, allowing disease to progress to an incurable stage.

The mechanism is not mysterious. Primary care serves as the entry point to the entire cancer care system. A family physician orders screening mammograms, evaluates new symptoms, coordinates referrals to specialists, and manages the chronic conditions that complicate cancer treatment. Lack of access to primary care may negatively affect the timeliness of diagnosis and also lead to delays in starting important anticancer therapies, the authors write. In metastatic disease, where every week of untreated progression matters, those delays can translate directly into lost survival time.

The study also identified an association between rural residence and early death. The researchers suggest this may reflect the logistical burden of travelling for treatment, which in Ontario is often coordinated through larger urban cancer centres. Patients living far from these hubs face longer journeys for chemotherapy, radiation consultations, and follow-up visits, which can be particularly taxing for people already weakened by advanced disease or constrained by income and employment. The authors call for future studies to determine effective ways of optimizing rural delivery of cancer care and integrating virtual care, which could reduce travel burdens and connect remote patients with oncology expertise.

Beyond diagnosis and treatment, the authors emphasize that primary care plays a pivotal role across the entire cancer continuum, from prevention and screening through treatment support, adverse-effect management, symptom control, and psychosocial and palliative care. The demand for cancer care is rising exponentially as the population ages and treatment options expand, and specialist oncologists are unlikely to be able to meet these care needs alone. Strengthening the primary care workforce and ensuring that every patient has a regular provider is therefore not merely a convenience but a structural determinant of cancer survival.

The study’s implications extend to policy. Optimizing cancer prevention and mammography screening in marginalized communities may reduce the likelihood of presenting with metastatic disease in the first place, the authors conclude, and the findings highlight the need for better primary care access across the province. As Ontario and other Canadian jurisdictions grapple with a growing shortage of family physicians, the research offers a concrete warning: when people fall through the cracks of primary care, cancers are found later, and some patients die within months of a diagnosis that earlier detection might have transformed. The research was supported in part by donor funding through London Health Sciences Foundation.

Subject of Research: Sociodemographic factors and primary care access associated with early death from de novo metastatic breast cancer in Ontario, Canada

Article Title: Breast cancer: marginalization, lack of primary care provider increase risk of early death from newly diagnosed metastatic cancer

Article References: Breast cancer: marginalization, lack of primary care provider increase risk of early death from newly diagnosed metastatic cancer. Original publication (Bibliographic details unavailable.)

Image Credits: AI Generated

DOI: Not provided

Keywords: breast cancer, metastatic cancer, primary care, health equity, marginalization, Ontario Marginalization Index, early mortality, mammography screening, rural health, CMAJ, health administrative data, cancer disparities

The study, led by Savannah R. Gonzales and Erika L. Moen at Dartmouth’s Geisel School of Medicine with collaborators at Columbia University and the University of Utah, drew on a uniquely rich federal data resource called SEER-CAHPS. This dataset links the National Cancer Institute’s Surveillance, Epidemiology, and End Results cancer registry with Medicare administrative claims and the Consumer Assessment of Healthcare Providers and Systems survey, which measures how Medicare beneficiaries rate their interactions with the health care system. The cohort consisted of 3,327 female Medicare beneficiaries diagnosed with stage I to III breast cancer between 2009 and 2019 who received surgical treatment and survived at least nine months after diagnosis.

The central question was whether regionalization, the deliberate steering of surgical procedures toward high-volume hospitals, shapes not just clinical outcomes but the entire multidisciplinary care journey and the patient’s lived experience of it. Prior research has documented compelling survival benefits at high-volume centers, and policies promoting regionalization of breast cancer surgery have followed. Yet the same literature reveals stark geographic inequities: 55 percent of the United States population lives more than one hour from the nearest National Cancer Institute-designated cancer center, and rural patients with common cancers travel a median of 89 minutes for surgical care compared with 36 minutes for urban residents. Regionalization, in other words, is not a free lunch.

To capture the full arc of treatment, the researchers employed a technique called state sequence analysis, a method borrowed from studies of chronic disease care pathways. Each patient’s nine-month trajectory following diagnosis was encoded as a two-dimensional state combining physician specialty, surgery, medical oncology, or radiation oncology, with facility classification. Patients remained in a state for seven days after each encounter or until the next cancer care visit, whichever came first. The team then used a dynamic Hamming distance alignment algorithm, which allows substitution costs to vary with observed transition rates, to calculate dissimilarity scores between every pair of sequences, followed by agglomerative clustering to identify distinct trajectory patterns.

The results revealed a striking stickiness in where patients receive care. Those who had their initial surgery at a regional facility spent an average of 52 days in regional care states versus 16 days in community states, while community surgery patients showed the mirror image, 54 days in community states versus 16 in regional ones. Among regional surgery patients who received chemotherapy, 48 percent obtained it exclusively at regional facilities, while 65.8 percent of community surgery patients received chemotherapy only at community facilities. Radiation therapy followed the same pattern. The surgical facility, it appears, anchors the entire adjuvant treatment journey.

Within each surgery cohort, the clustering algorithm identified three distinct trajectory clusters that were largely complementary across the two groups. One cluster in each cohort was dominated by lumpectomy patients who went on to receive adjuvant radiation, another by older patients with fewer oncologist visits and minimal chemotherapy or radiation, and a third by stage III patients almost universally treated with chemotherapy. But the predominant cluster differed dramatically. Among regional surgery patients, 59 percent fell into a cluster spending 233 of their trajectory days without any cancer care visit, a pattern in which only one-third of lumpectomy patients received adjuvant radiation. Among community surgery patients, the largest cluster, 49 percent, was characterized by lumpectomy followed by radiation in roughly 81 percent of cases.

The authors offer two competing interpretations of this divergence. Regional facilities may be better positioned to identify low-risk cases, particularly women over 70, in whom clinical guidelines support safely omitting radiation after breast-conserving surgery. Alternatively, the higher radiation rates at community facilities may reflect improved access through reduced travel burden and greater colocation of services. Prior work has shown that patients facing longer travel distances are more likely to receive mastectomy over breast-conserving surgery and less likely to receive guideline-concordant adjuvant radiation, even after accounting for cancer stage.

On the experience measures themselves, the findings were subtle but significant. In a linear mixed-effects model with surgical facility as a random intercept, community surgery was associated with a 3.5-point higher score on the composite measure for getting needed care, which includes questions about ease of accessing specialty appointments, with a 95 percent confidence interval of 0.10 to 6.9 and a p-value of 0.043. No significant differences emerged for getting care quickly, care coordination, or doctor communication. Notably, rural residence did not modify the effect of facility classification, meaning the community-facility advantage held for both rural and urban patients. Intriguingly, rural residence itself was associated with higher scores for getting care quickly, 8.8 points, and doctor communication, 6.3 points, as a main effect, echoing prior findings that rural patients sometimes report better care experiences than urban counterparts, possibly due to lower expectations or reduced travel burden at familiar home facilities.

The authors caution that their data cannot discern the mechanisms behind the access gap. One possibility is selection bias: referral to regional facilities may concentrate more complex patients whose care needs are harder to address. Another is fragmentation: regional surgery patients were more likely to receive adjuvant treatment across both regional and community facilities, potentially splitting their care across settings and creating barriers to accessing specialty appointments. The authors suggest that patient navigation services, which have demonstrated benefits across the cancer care continuum, could be targeted toward patients requiring multidisciplinary treatment plans or travel between multiple facilities.

The study has important limitations. The SEER-CAHPS cohort is restricted to women over 65 enrolled in Traditional Medicare within SEER regions, and the analytic sample of 652 patients who completed a survey within two years of diagnosis is smaller than typical SEER-Medicare studies. The median age of breast cancer diagnosis in the United States is 62, meaning over half of all cases are not represented. Encrypted ZIP codes prevented direct calculation of travel distance, and Medicare claims capture only a fraction of each facility’s total surgical volume, forcing the researchers to use HCUP-based hospital size criteria as a proxy rather than true procedure-volume thresholds. Still, the core message stands: the benefits of regionalization must be weighed against the patient’s experience of the journey itself, and for many women, the closer, smaller hospital may deliver something the regional center cannot, a sense that care is truly within reach.

Subject of Research: A retrospective cohort study linking Medicare claims, cancer registry data and CAHPS surveys to compare breast cancer care trajectories and patient experiences by surgical facility type.

Article Title: Associations of surgical breast cancer treatment at regional or community hospitals with patient-reported experience measures

Article References: Gonzales, S. R., Ramesh, U., O’Malley, A. J., Brooks, G. A., Onega, T., & Moen, E. L. (2026). Associations of surgical breast cancer treatment at regional or community hospitals with patient-reported experience measures. Breast Cancer Research and Treatment, 220(1), Article 4. https://doi.org/10.1007/s10549-026-08105-1

Image Credits: AI Generated

DOI: 10.1007/s10549-026-08105-1

Keywords: breast cancer, regionalization of care, patient-reported experience measures, SEER-CAHPS, community hospitals, high-volume hospitals, state sequence analysis, adjuvant therapy, rural health, care trajectories, surgical oncology, health services research

The research, published in BMC Public Health by Yasin Sağlam, a public health specialist and District Health Director in Vezirköprü, Samsun, surveyed 782 students in grades 9 through 12 across all public high schools in the district between April and June 2026. Participants completed a sociodemographic questionnaire along with two validated instruments: the Climate Change Worry Scale, or CCWS, which quantifies the intensity of climate-related concern, and the Generalized Anxiety Disorder-7 scale, known as GAD-7, a widely used clinical screening tool for generalized anxiety symptoms. The study was approved by the Samsun University Non-Interventional Clinical Research Ethics Committee and carried out with written informed consent from parents or guardians of participants under 18, in accordance with the Declaration of Helsinki.

The headline numbers are striking. The mean CCWS score among the students was 30.31 with a standard deviation of 9.54, and a median of 30.0 with an interquartile range of 23.0 to 37.0. More alarming from a clinical standpoint, the mean GAD-7 score was 8.78 with a standard deviation of 6.58, and 353 students, or 45.1 percent of the sample, scored at or above the GAD-7 clinical cut-off of 10, the threshold conventionally used to flag probable generalized anxiety disorder. In other words, nearly half of the adolescents surveyed were experiencing anxiety symptoms at a level that would typically warrant clinical evaluation, and their climate worry scores were far from trivial.

The correlation between the two measures was the study’s most consequential statistical finding. Climate change worry and generalized anxiety scores were moderately correlated, with a Spearman coefficient of 0.573 and a p-value below 0.001. This means that students who worried more intensely about climate change also tended to report more generalized anxiety symptoms, and vice versa. The relationship is correlational rather than causal, so the data cannot determine whether climate worry drives anxiety, whether anxious individuals are more prone to ruminate on global threats, or whether both share common underlying drivers. But the strength of the association, in a sample of this size, makes it difficult to dismiss as statistical noise.

Multiple linear regression analysis revealed which factors independently predicted climate change worry. Female sex emerged as the strongest sociodemographic predictor, with a standardized beta coefficient of 0.302. The GAD-7 score itself was the single strongest predictor overall at 0.339, followed closely by heavy social media use, defined as more than six hours per day, which carried a beta of 0.275. Reporting an extreme weather event in the local area within the past year contributed a smaller but still significant effect at 0.106, and school type also independently predicted worry levels. Together, these variables explained 43.7 percent of the variance in climate change worry, with an adjusted R-squared of 0.430, a substantial proportion for research on psychological phenomena in real-world populations.

The demographic patterns within the raw data reinforce the regression findings. Median CCWS scores were markedly higher among female students than male students, at 34.0 versus 26.0, a difference with a p-value below 0.001. Students who reported experiencing an extreme weather event in their area during the previous year scored higher on climate worry than those who did not, with medians of 33.0 versus 30.0 and a p-value of 0.005. Most dramatically, climate worry rose steadily across categories of self-reported social media use: students spending less than one hour daily on social platforms had a median CCWS score of 25.0, those using social media between one and six hours scored a median of 30.0, and those exceeding six hours per day reached a median of 36.0, with the overall difference significant at p below 0.001.

The social media gradient deserves particular attention. A dose-response pattern of this kind, where worry increases stepwise with each increment of exposure time, is consistent with the hypothesis that digital information environments amplify climate-related distress among adolescents. Constant exposure to climate news, disaster imagery, and online discourse about environmental collapse may keep the threat psychologically salient in ways that traditional media or school curricula do not. The study cannot prove causation, since it is possible that students who are already more worried about climate change seek out more climate-related content online. But the consistency of the gradient across usage categories, combined with the independent predictive power of heavy use in the regression model, strengthens the case that social media plays a meaningful role in shaping the emotional landscape of climate concern among teenagers.

The finding that local experience of extreme weather independently predicts climate worry adds an important geographic dimension. Rural districts like Vezirköprü are often assumed to be insulated from the psychological effects of climate change because they lack the dense media environments and activist cultures of large cities. Yet direct encounters with floods, droughts, storms, or heatwaves in one’s own community appear to translate abstract global narratives into concrete personal vulnerability. This suggests that as extreme weather events become more frequent under continued warming, the mental health burden on rural adolescents may grow even if their communities remain far from the coastal megacities that dominate climate coverage.

The high prevalence of generalized anxiety symptoms in the sample, with 45.1 percent at or above the clinical cut-off, also warrants independent concern regardless of its relationship to climate worry. Adolescent anxiety is a well-documented public health problem, and rural areas frequently lack adequate mental health services. The study’s findings suggest that school-based interventions addressing climate-related distress could serve a dual purpose: they may reduce a specific source of worry while simultaneously providing an entry point for identifying students with broader anxiety disorders who need clinical support. The author recommends that school-based mental health and climate literacy programs address climate-related distress, with particular attention to female students and heavy social media users, the two groups identified as most vulnerable.

Published as an open-access article in BMC Public Health on 16 October 2026, the study carries the DOI 10.1186/s12889-026-29987-2 and adds to a growing international literature on eco-anxiety, the term increasingly used to describe chronic worry about environmental degradation. What distinguishes this contribution is its rural focus and its use of a validated clinical anxiety measure alongside a dedicated climate worry scale in the same sample. As climate change accelerates and extreme weather becomes more common, understanding how adolescents in less-studied settings process these threats will be essential for designing mental health support that meets them where they are. This study provides a rigorous baseline for that effort in rural Türkiye and a template for similar research elsewhere.

Subject of Research: Climate change worry and generalized anxiety among rural Turkish high school students

Article Title: Climate change worry and generalized anxiety among high school students in a rural district of Türkiye: a cross-sectional study

Article References: Sağlam, Y. (2026). Climate change worry and generalized anxiety among high school students in a rural district of Türkiye: a cross-sectional study. BMC Public Health. https://doi.org/10.1186/s12889-026-29987-2

Image Credits: AI Generated

DOI: 10.1186/s12889-026-29987-2

Keywords: climate change, eco-anxiety, generalized anxiety, adolescent mental health, social media, extreme weather, Türkiye, high school students, public health, GAD-7, Climate Change Worry Scale, rural health

The study, published in BMC Medical Imaging by Saad Arsalan Wasti of King Edward Medical University, Areesha Wasti of Continental Medical College, and Dori Woldu of Butaro Level Two Teaching Hospital, examined mortality associated with radiological procedures and radiotherapy in the United States between 1999 and 2019. Rather than relying on single-institution case series or voluntary reporting databases, the researchers turned to one of the most comprehensive mortality resources available: the Centers for Disease Control and Prevention’s WONDER Multiple Cause of Death database, which compiles every recorded death in the country along with the coded conditions and circumstances that contributed to it.

The methodological backbone of the study is the International Classification of Diseases, Tenth Revision, or ICD-10, the standardized coding system used on death certificates nationwide. Within that system, the code Y84.2 specifically designates deaths in which a radiological procedure or radiotherapy was recorded as either the underlying cause or a contributing factor. By searching for this code across the full 21-year window, the team identified a total of 22,542 deaths associated with radiological procedures and radiotherapy. That figure, spread across two decades and a population of more than 300 million, underscores how uncommon such deaths are, but the researchers were less interested in the raw count than in how the rate changed over time and who was most affected.

To make fair comparisons across years, the authors calculated both crude mortality rates and age-adjusted mortality rates per 100,000 population. Age adjustment is a critical statistical technique in epidemiology: because the American population has grown steadily older over the study period, a naive comparison of raw death counts could falsely suggest rising risk simply because there are more elderly people to begin with. The overall age-adjusted mortality rate across the study period was 0.33 per 100,000 population, with a confidence interval of 0.33 to 0.33, reflecting the enormous sample size and the precision that national-level data afford. In practical terms, for every 300,000 Americans, roughly one death certificate in a given year carried this radiological or radiotherapy-related code.

The headline finding is a clear and statistically robust decline. In 1999, the age-adjusted mortality rate stood at 0.50 per 100,000 population; by 2019 it had fallen to 0.24, a reduction of more than half. The researchers quantified this trajectory using Joinpoint regression, a technique that fits a series of joined straight lines to mortality data on a logarithmic scale and identifies the years at which the trend changes direction. From the fitted model they calculated the average annual percent change, or AAPC, over the whole period: minus 3.62 percent per year, with a 95 percent confidence interval running from minus 4.17 to minus 3.20 percent, and a P value below 0.000001. In plain language, the decline was steady, continuous, and almost certainly not a statistical fluke.

What drove this improvement? The study’s observational design cannot assign causation, but the timeline coincides with well-documented advances in radiation delivery and safety culture. Modern linear accelerators with intensity-modulated radiation therapy, image-guided targeting, and sophisticated treatment planning have progressively reduced the dose delivered to healthy tissue. In diagnostic and interventional radiology, dose-reduction protocols, better equipment regulation, and the growth of radiation safety programs have similarly tightened the margins of error. The steady, year-on-year nature of the decline, captured by the Joinpoint analysis, is consistent with a gradual accumulation of these safety improvements rather than any single turning point.

Yet the disaggregated data reveal a more complicated story. Men experienced higher mortality than women, at 0.38 versus 0.28 per 100,000 population, although both sexes showed significant declines over time with P values below 0.000001. Age was the most striking stratifier: mortality rose progressively with advancing age, peaking among adults aged 85 and older, whose crude mortality rate reached 2.94 per 100,000 population, nearly nine times the national average. This gradient likely reflects a combination of factors, including greater frailty, higher rates of cancer treatment in the elderly, and reduced physiological reserve for weathering procedural complications. It also serves as a reminder that procedure-related risk must always be weighed against the therapeutic benefit that imaging and radiotherapy provide to the very same older patients.

Geography and community type mattered as well. Rural areas recorded higher mortality rates than urban areas, at 0.38 versus 0.32 per 100,000 population, and the Midwest demonstrated the highest regional mortality rates among the census regions. The rural-urban gap is particularly notable because it echoes broader patterns in American health services research: rural hospitals often have older equipment, thinner staffing, and longer transfer distances when complications arise. The authors did not identify the mechanisms behind these disparities, but the finding aligns with a growing body of evidence that where a patient lives can shape the safety of the care they receive, independent of the procedure itself.

The study has limitations that the authors and readers should keep in view. Death certificate coding depends on the accuracy and consistency of the physicians and medical examiners who complete the certificates, and Y84.2 may be underused or inconsistently applied, particularly when a procedure-related death is obscured by the patient’s underlying illness. The database also cannot distinguish between diagnostic imaging, interventional procedures, and therapeutic radiotherapy, nor can it capture near-misses and nonfatal complications that never reach a death certificate. Because the analysis is ecological, it identifies associations at the population level rather than causal pathways in individual patients. These caveats do not undermine the central trends, but they do mean the absolute numbers should be interpreted as a floor rather than a ceiling.

Even so, the significance of the work lies in its scale and its framing. Most evidence on radiation-related harm comes from voluntary incident reporting systems, which are known to undercount, or from specialized registries covering narrow procedure types. A twenty-one-year, all-ages, all-states analysis provides a baseline against which future safety interventions can be measured. The authors suggest their findings may help inform future studies evaluating procedural safety and healthcare disparities, and the disparity map they have drawn, older adults, men, rural residents, and residents of certain regions, gives researchers and policymakers concrete places to look. For a field that touches nearly every cancer patient and countless diagnostic workups, knowing that mortality has fallen by half while identifying who remains at elevated risk is exactly the kind of evidence that turns good intentions into targeted policy. The machines that peer inside our bodies and burn away our tumors have never been safer; the task now, this study implies, is to make sure that safety reaches every corner of the country.

Subject of Research: National trends and demographic and geographic disparities in mortality associated with radiological procedures and radiotherapy in the United States from 1999 to 2019

Article Title: National trends and disparities in mortality associated with radiological procedures and radiotherapy (1999–2019)

Article References: Wasti, S. A., Wasti, A., & Woldu, D. (2026). National trends and disparities in mortality associated with radiological procedures and radiotherapy (1999–2019). BMC Medical Imaging. https://doi.org/10.1186/s12880-026-02783-5

Image Credits: AI Generated

DOI: 10.1186/s12880-026-02783-5

Keywords: radiotherapy, radiological procedures, mortality trends, health disparities, CDC WONDER, ICD-10, Joinpoint regression, age-adjusted mortality, rural health, radiation safety, epidemiology, BMC Medical Imaging

The headline figure from the survey is a self-reported tuberculosis prevalence of approximately 150 per 100,000 population, a figure expressed in the study as 150 per lakh, the South Asian unit of one hundred thousand. While that number sits within the broad range of official estimates for the country, what makes the study valuable is not simply the prevalence estimate itself but the parallel measurement of six well-established vulnerability factors that make individuals more likely to progress from latent infection to active disease. These are HIV infection, current smoking, silicosis, occupational exposure to silica dust, diabetes mellitus, and a persistent cough lasting more than two weeks, the classic warning symptom that should trigger diagnostic evaluation.

The rationale for mapping these factors together stems from a growing recognition in TB control strategy that comorbidities and occupational exposures in otherwise uninfected individuals create pockets of heightened susceptibility. HIV infection dramatically increases the risk that latent Mycobacterium tuberculosis infection will activate, because the virus depletes the CD4-positive T cells that normally keep the bacillus in check. Diabetes mellitus, which has tripled in prevalence across India in recent decades, impairs immune function in ways that roughly double or triple TB risk. Smoking damages the mucociliary clearance mechanisms of the airways, while silica dust exposure and established silicosis disrupt macrophage function in the lungs, the very cells responsible for engulfing and destroying tubercle bacilli. Each of these conditions, on its own, marks a population that could benefit from more intensive screening.

To build the dataset, the researchers designed a multi-stage random sampling framework that aimed to capture a genuinely representative slice of rural life. In each of the six districts, two administrative blocks were selected at random, and within each block, villages were again chosen randomly. Rather than sampling individual households within those villages, the team employed a universal sampling technique, meaning every household in the selected villages was approached for participation. This choice matters methodologically, because universal sampling within clusters avoids the selection biases that can creep in when enumerators choose which homes to visit, and it maximizes coverage of populations that are often missed by facility-based surveillance, such as people who never seek care or who cannot easily travel to a clinic.

Data collection relied on a pre-tested semi-structured questionnaire administered through face-to-face interviews at every eligible household. Pre-testing the instrument is a standard but crucial step, since it allows researchers to identify ambiguous wording, translation problems, or questions that respondents consistently misunderstand before the full survey begins. The interviews captured demographic details alongside self-reported TB status and the selected vulnerability factors. Descriptive statistical analysis was then performed, with results expressed as frequencies and percentages. The final sample comprised 52 percent males and 47 percent females, with 77 percent of the population aged 15 years or older, an age distribution that aligns with the typical demographic structure of rural India and ensures that adult prevalence patterns are well represented.

The measured prevalence of the vulnerability factors reveals a layered risk landscape. HIV-reactive individuals made up 0.9 percent of the surveyed population, current smokers accounted for 5 percent, silicosis was reported at 1.2 percent, occupational exposure to silica dust at 1.1 percent, diabetes mellitus at 1.4 percent, and a cough lasting more than two weeks at 4 percent. Each of these percentages, multiplied across a rural population of hundreds of millions nationally, translates into enormous numbers of people. The 4 percent reporting persistent cough is particularly significant for programmatic purposes, because cough of more than two weeks is the cardinal symptom that NTEP screening algorithms use as a trigger for sputum testing and, increasingly, molecular diagnostics such as the GeneXpert platform.

It is worth pausing on the relationship between these factors and the biology of TB progression. An estimated quarter of the world’s population carries latent TB infection, in which the bacteria sit dormant within granulomas in the lungs, held in check by the immune system. Progression to active disease occurs in roughly 5 to 10 percent of latently infected individuals over a lifetime, but that risk is not evenly distributed. In a person living with HIV, the annual risk of developing active TB can be more than tenfold higher than in an immunocompetent person. In someone with untreated diabetes, the risk is estimated at two to three times baseline. In silicosis, the granuloma-forming macrophages that normally wall off the infection are progressively destroyed by silica particles, creating an environment where tubercle bacilli can flourish, and TB risk in silicotics has been reported to be several times that of the general population.

The implications for active case finding are the study’s central contribution. Passive case finding, in which patients are diagnosed only after they present themselves to a health facility, has long been known to miss a substantial fraction of TB cases, particularly in rural and underserved areas where access barriers, stigma, and low health literacy suppress care-seeking. Active case finding, by contrast, sends screening into communities, identifying infectious individuals earlier in their disease course, interrupting transmission chains, and reducing the duration for which untreated patients spread the bacillus through coughing. The NTEP has embraced targeted active case finding, but targeting requires maps. Knowing which villages and which demographic or occupational groups carry elevated vulnerability allows program managers to concentrate expensive screening resources where they will yield the most diagnosed cases rather than distributing them uniformly.

The study’s multipronged approach, simultaneously measuring six vulnerability factors in a single massive cohort, is what distinguishes it from narrower prevalence surveys. Many earlier studies in India have examined one comorbidity at a time, for instance diabetes prevalence among TB patients or smoking rates in a single district. By capturing the full profile in one coordinated effort, the authors provide a denominator-based picture: for every vulnerability factor, program planners can now estimate how many people in comparable rural settings carry that risk marker. The very large sample size, exceeding eighty thousand individuals, gives the descriptive estimates considerable stability, which is essential when those estimates are used to project resource needs for screening campaigns, diagnostic capacity, and drug supplies.

Certain limitations are inherent to the design and deserve honest acknowledgment. The study relies on self-reported TB status and self-reported conditions, which means some cases may be undercounted if respondents were unaware of their infection or reluctant to disclose it, while clinical confirmation such as sputum microscopy or molecular testing was not performed as part of the survey itself. Self-reported diabetes likewise may miss undiagnosed cases, a substantial concern in India where a large share of people with diabetes are believed to be unaware of their condition. Despite these caveats, the scale and design of the survey make it a valuable strategic asset. As India pursues its goal of TB elimination, studies of this kind demonstrate that the path forward runs through granular, community-level surveillance of both the disease and the conditions that fuel it, turning the abstract arithmetic of a national epidemic into an actionable map of who needs screening, where, and why.

Subject of Research: Self-reported tuberculosis prevalence and associated vulnerability factors in rural populations across six districts of India

Article Title: Self-reported prevalence of tuberculosis and selected associated vulnerability factors among rural populations in six districts of India: A community-based cross-sectional study

Article References: Anand, P. K., Singh, M., Banerjee, P., Sahay, S., Bangar, S., Ghosh, B. R., Chalga, M. S., Pappu, A., Das, V., Gupta, S., Kumar, A., & Pandey, D. (2026). Self-reported prevalence of tuberculosis and selected associated vulnerability factors among rural populations in six districts of India: A community-based cross-sectional study. PLOS One, 21(10), e0360758. https://doi.org/10.1371/journal.pone.0360758

Image Credits: AI Generated

DOI: 10.1371/journal.pone.0360758

Keywords: tuberculosis, India, prevalence, HIV, diabetes mellitus, silicosis, smoking, silica dust exposure, active case finding, National Tuberculosis Elimination Programme, cross-sectional study, rural health

The research team recruited participants from three groups connected to the Australian College of Rural and Remote Medicine, the national training body for rural generalist medicine: registrars undertaking rural generalist training, the rural clinical supervisors who oversee their day-to-day work, and medical educators involved in the formal curriculum. Each group took part in semi-structured interviews conducted over Zoom, which were recorded and transcribed for analysis. The researchers then applied a combination of inductive coding, in which themes emerge from the data itself, and deductive coding guided by Mezirow’s theory of transformative learning, a well-established framework in adult education that describes how learners’ frames of reference are fundamentally reshaped by disorienting experiences, critical reflection and dialogue with others.

The analysis surfaced a set of interlocking themes that together trace the registrar’s journey. The first concerned how registrars themselves understand clinical courage: not recklessness, but the willingness to act at the full extent of one’s competence when no alternative care is available, while recognising the limits of that competence. A second theme described the development of rural generalist clinical expertise, the slow accumulation of skills and judgement across disciplines that gives courage its foundation. A third, strikingly social theme showed that community engagement increases motivation, as registrars who come to know their patients as neighbours feel a stronger pull to provide care that would otherwise be inaccessible.

One of the most conceptually interesting findings is the theme the authors describe as adapting practice to prioritise patient values and ties to place. In urban tertiary settings, best practice is often defined by guidelines written for well-resourced hospitals. In a rural context, registrars described a shift in perspective: the patient is understood as a person embedded in a community, a family and a landscape, and clinically courageous practice means adapting guideline-driven care to honour what the patient values and where the patient lives. This represents a genuine transformation in the learner’s frame of reference, precisely the kind of perspective shift Mezirow’s theory predicts when professionals confront situations their original training did not prepare them for.

Alongside this shift in how care is conceived, the study documented a parallel shift in accountability. Trainees begin their careers primarily answerable to their supervisor or consultant, the senior clinician who reviews their decisions and carries ultimate responsibility. As clinical courage develops, registrars move toward shared decision making with patients, in which the doctor and the patient jointly weigh risks, benefits and personal circumstances. This redistribution of accountability is not a loss of oversight but a maturation of professional identity, and the researchers found that supervisors and educators play a crucial role in supporting registrars through this transformational learning journey rather than simply leaving them to sink or swim.

Courage, however, does not develop in a vacuum of approval. The final theme identified in the study, managing judgement, addresses a reality that rural clinicians know intimately: clinically courageous practice can attract censure from outsiders who do not understand the rural context. A metropolitan specialist reviewing a rural doctor’s decision may see only deviation from protocol, not the constraints of distance, time and resources under which the decision was made. Registrars must learn to withstand this external judgement, to reflect critically on their own actions without being paralysed by criticism from those unfamiliar with rural medicine, and to trust the local reasoning that guided them. The researchers argue that managing this judgement is an integral part of developing clinical courage, not a peripheral stressor.

The technical significance of this work lies in its explicit use of transformative learning theory as an analytical lens. By deductively coding interviews against Mezirow’s stages, the team was able to map registrar experiences onto a recognised developmental trajectory: a disorienting encounter with rural clinical reality, critical self-reflection, rational discourse with supervisors and peers, and ultimately a revised, more autonomous professional perspective. This theoretical grounding matters because it converts what might otherwise be anecdote into a structured model that training programmes can act upon. It suggests that the discomfort registrars feel when first facing rural cases alone is not a problem to be eliminated but a necessary catalyst in the learning process, provided it is accompanied by reflective dialogue and adequate supervision.

The practical implications for medical education are direct. The authors advocate that clinical courage should be made explicit throughout rural generalist registrar training, named and discussed in the curriculum rather than left implicit in the hidden curriculum of daily practice. They further propose that documenting clinically courageous management plans could facilitate teaching and learning, giving registrars and supervisors a concrete artefact around which to discuss reasoning, risk and values. Such documentation would also help registrars articulate, to themselves and to external reviewers, why a particular rural decision was defensible, directly supporting the theme of managing judgement.

There is also a workforce dimension that gives the study broader urgency. Rural communities worldwide struggle to recruit and retain doctors, and previous work has associated clinical courage with sustained clinical work in rural areas. If courage develops over time and is reinforced by community connection, then training pathways that deliberately cultivate it, through supervised exposure to full-scope practice, reflective supervision and genuine community immersion, may help produce doctors who not only can serve rural populations but choose to stay. The authors note that their insights may be transferable to registrars training for rural medicine in other countries, a claim strengthened by the international composition of the team, which includes researchers based in South Africa as well as Australia, and by the study’s dedication to the late Professor Jill Konkin of Alberta, Canada, a pioneer of clinical courage research since the field’s inception in 2016.

Funded by an Australian College of Rural and Remote Medicine Education Research Grant and approved by the University of Adelaide Human Research Ethics Committee, the study arrives at a moment when rural health systems are under visible strain. Its central message reframes an old ideal: the brave country doctor is not a romantic archetype but the product of a specific, describable educational process, one that blends accumulating expertise, transforming perspective, sharing decisions with patients, and learning to stand by difficult choices in the face of outside criticism. Making that process explicit, the researchers argue, is the next step in ensuring that remote communities continue to have access to care that would otherwise simply not exist.

Subject of Research: Development of clinical courage in rural generalist medical registrars

Article Title: Developing clinical courage in rural generalist registrars: a qualitative study

Article References: Stewart, R., Couper, I., Campbell, D., Williams, S., Moody, E., Padley, J., White, L., Pellegrini, D., & Walters, L. (2026). Developing clinical courage in rural generalist registrars: a qualitative study. BMC Medical Education. https://doi.org/10.1186/s12909-026-10610-2

Image Credits: AI Generated

DOI: 10.1186/s12909-026-10610-2

Keywords: clinical courage, rural generalist, medical education, registrars, transformative learning, Mezirow, rural health, Australia, ACRRM, supervision, community engagement, qualitative research